Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis

NCT01509339 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.

NCT NCT01509339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01509339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis
Lead sponsor
Case Western Reserve University
Phase
Phase 1
Overall status
Withdrawn
Start date
January 31, 2012
Completion date
December 23, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, methicillin-resistant staphylococcus aureus